Central Nervous System Metastases in Pediatric Patients with Ewing Sarcoma.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
02 Feb 2024
02 Feb 2024
Historique:
received:
13
09
2023
accepted:
10
01
2024
medline:
6
2
2024
pubmed:
6
2
2024
entrez:
5
2
2024
Statut:
aheadofprint
Résumé
Metastatic central nervous system (CNS) involvement is rare in pediatric primary extracranial Ewing sarcoma (ES). We describe the incidence and course of 6 patients with extracranial ES who developed metastatic CNS lesions treated at a single institution. The median time to CNS disease detection was 16.3 months (10.0-28.3 months). Event-free and overall survival after CNS disease detection were 1.9 months (0.4 to 10.3 months) and 4.6 months (1.1 to 50.9 months), respectively. One patient was alive at the time of analysis. Clinical status and ability to obtain disease control should be considered when making decisions regarding aggressive interventions in these patients with poor prognosis.
Identifiants
pubmed: 38316140
doi: 10.1097/MPH.0000000000002825
pii: 00043426-990000000-00372
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Esiashvili N, Goodman M, Marcus RB Jr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol. 2008;30:425–430.
Cherif El Asri A, Benzagmout M, Chakour K, et al. Primary intracranial pPNET/Ewing sarcoma: Diagnosis, management, and prognostic factors dilemma-A systematic review of the literature. World Neurosurg. 2018;115:346–356.
Deshpande G, Epari S, Gupta C, et al. Primary intracranial Ewing sarcoma/ peripheral primitive neuroectodermal tumor, an entity of unacquaintance: a series of 8 cases. Childs Nerv Syst. 2021;37:839–849.
Colak A, Berker M, Ozcan OE, et al.CNS involvement in Ewing’s sarcoma. A report of 12 cases.Acta Neurochir (Wien). 1991;113:48–51.
Haveman LM, Ranft A, Berg HVD, et al. Primary and metastatic intracranial ewing sarcoma at diagnosis: Retrospective international study and systematic review. Cancers (Basel). 2020;12:1675.
Bekiesinska-Figatowska M, Duczkowska A, Duczkowski M, et al. CNS metastases from bone and soft tissue sarcomas in children, adolescents, and young adults: are they really so rare? Biomed Res Int. 2017;2017:1456473.
Bouffet E, Doumi N, Thiesse P, et al. Brain metastases in children with solid tumors. Cancer. 1997;79:403–410.
Capitini CM, Derdak J, Hughes MS, et al. Unusual sites of extraskeletal metastases of Ewing sarcoma after allogeneic hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2009;31:142–144.
Postovsky S, Ash S, Ramu IN, et al. Central nervous system involvement in children with sarcoma. Oncology. 2003;65:118–124.
Shuper A, Cohen IJ, Mor C, et al. Metastatic brain involvement in Ewing family of tumors in children. Neurology. 1998;51:1336–1338.
Parasuraman S, Langston J, Rao BN, et al. Brain metastases in pediatric Ewing sarcoma and rhabdomyosarcoma: The St. Jude Children’s Research Hospital experience. J Pediatr Hematol Oncol. 1999;21:370–377.